GlobeNewswire Inc.··Levi & Korsinsky, LlpSoleno Therapeutics Hit with Securities Fraud Lawsuit Over Hidden Drug Safety Risks
Soleno Therapeutics faces class action lawsuit for allegedly concealing drug safety risks including fluid retention and diabetes complications. Affected shareholders can claim losses through May 2026.
SLNOsecurities fraudclass action lawsuit